<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26690042</article-id>
      <article-id pub-id-type="pmc">4696703</article-id>
      <article-id pub-id-type="publisher-id">15-1212</article-id>
      <article-id pub-id-type="doi">10.3201/eid2201.151212</article-id>
      <article-categories>
        <subj-group subj-group-type="second-type">
          <subject>Expedited</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Letter</subject>
        </subj-group>
        <subj-group subj-group-type="TOC-title">
          <subject>Ebola Virus Disease Complicated by Late-Onset Encephalitis and Polyarthritis, Sierra Leone</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ebola Virus Disease Complicated by Late-Onset Encephalitis and Polyarthritis, Sierra Leone</article-title>
        <alt-title alt-title-type="running-head">EVD Complicated by Encephalitis and Polyarthritis</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Howlett</surname>
            <given-names>Patrick</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brown</surname>
            <given-names>Colin</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Helderman</surname>
            <given-names>Trina</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brooks</surname>
            <given-names>Tim</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lisk</surname>
            <given-names>Durodamil</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Deen</surname>
            <given-names>Gibrilla</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Solbrig</surname>
            <given-names>Marylou</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lado</surname>
            <given-names>Marta</given-names>
          </name>
        </contrib>
        <aff id="aff1">Kings Sierra Leone Partnership, Freetown, Sierra Leone (P. Howlett, M. Lado); </aff>
        <aff id="aff2">University College London Hospital, London, UK (C. Brown); </aff>
        <aff id="aff3">Medair, Ecublens, Switzerland (T. Helderman); </aff>
        <aff id="aff4">Public Health England, Porton Down, UK (T. Brooks); </aff>
        <aff id="aff5">Connaught Hospital, Freetown (D. Lisk, G. Deen); </aff>
        <aff id="aff6">University of Kansas, Lawrence, Kansas, USA (M. Solbrig)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Patrick Howlett, Kings Sierra Leone Partnership, 2nd Floor Connaught Hospital, Lightfoot Boston Street, Freetown, Sierra Leone; email: <email xlink:href="patrick.howlett@gmail.com">patrick.howlett@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <volume>22</volume>
      <issue>1</issue>
      <fpage>150</fpage>
      <lpage>152</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Ebola virus disease</kwd>
        <kwd>Ebola virus</kwd>
        <kwd>encephalitis</kwd>
        <kwd>polyarthritis</kwd>
        <kwd>viral persistence</kwd>
        <kwd>Sierra Leone</kwd>
        <kwd>viruses</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Ebola virus (EBOV) disease is usually an acute illness, but increasing evidence exists of persistent infections and post-Ebola syndromes. We report a case of EBOV encephalitis.</p>
    <p>A 30-year-old woman with no known EBOV contact sought treatment at an Ebola isolation unit in Freetown, Sierra Leone, on January 1, 2015 (day 7 of illness). She was afebrile and weak, but ambulatory, with a history of fever, vomiting, diarrhea, headache, and muscle and joint pain. According to local protocol, she was given oral antimalarial, antimicrobial, and antiemetic drugs and oral rehydration therapy. On day 8 of illness, after testing EBOV PCR&#x2013;positive (cycle threshold [C<sub>t</sub>] value of 23.5) (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>), she was given intravenous ceftriaxone (2 g) for 7 days, artesunate (180 mg) for 3 days, and Ringer&#x2019;s lactate (4&#x2013;6 L) with supplemental KCl for 5 days.</p>
    <p>During days 13&#x2013;15, the patient improved, moving independently and talking. On day 16, she became confused; by day 20, she was unresponsive to voices. Intravenous ceftriaxone (2 g) and artesunate (180 mg) were administered for an additional 7 and 3 days, respectively. On days 28 and 29, she was still unconscious; serum PCR test results on both days were negative for EBOV. On day 29, she was transferred to Connaught Hospital in Freetown, where she had a Glasgow Coma Scale score of 9/15 (E3, V1, M5) but no localizing or focal signs. She was given intravenous fluconazole (800 mg 1&#xD7;/d). Admission blood test results showed anemia, elevated <bold>alanine aminotransferase</bold> and C-reactive protein, and low creatinine (<xref ref-type="local-data" rid="SD1">Technical Appendix</xref>). HIV test results were negative. </p>
    <p>On day 34, large-joint polyarthritis of the right shoulder, left elbow, and left knee developed. Affected joints appeared normal on radiographs, and synovial fluid (15 mL) from the left knee was EBOV PCR negative. She was given diclofenac (50 mg 2&#xD7;/d) and 1 intramuscular dose of methylprednisolone (80 mg). Concurrent blood PCR on day 34 was negative.</p>
    <p>By day 41 she was more alert, although her family reported she had slowed responses. Lumbar puncture was performed; opening pressure (30 cm H<sub>2</sub>O) was elevated, and cerebrospinal fluid (CSF) was EBOV PCR&#x2013;positive (C<sub>t</sub> value 37.6), as determined by using the Public Health England in-house, optimized version of the Trombley assay (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>) with a cutoff C<sub>t</sub> value of 40. Concurrent catheter specimens of urine and blood samples tested EBOV-negative. FilmArray (BioFire Diagnostics, Salt Lake City, UT, USA) testing showed methicillin-resistant <italic>Staphylococcus aureus</italic> and <italic>Klebsiella pneumoniae</italic> in CSF and mixed pathogens in urine. A computer tomographic scan image of the patient&#x2019;s head showed substantial cerebral atrophy without hydrocephalus (<xref ref-type="fig" rid="F1">Figure</xref>).</p>
    <fig id="F1" fig-type="figure" position="float">
      <label>Figure</label>
      <caption>
        <p>Representative axial cuts from noncontrast head computed tomography scan imaging of a 30-year-old woman with encephalitis resulting from Ebola virus infection, Sierra Leone. Images show global atrophy in keeping with nonobstructive ventriculomegaly and no periventricular low attenuation: A) subcortical atrophy; B) cortical atrophy. There was no evidence of hydrocephalus, previous stroke, or intracranial hemorrhage. A cavum septum pellucidum was noted in other images. </p>
      </caption>
      <graphic xlink:href="15-1212-F"/>
    </fig>
    <p>On day 44, an underarm sweat swab sample was PCR-positive (C<sub>t</sub> value 39.6) and a buccal swab sample PCR-negative for EBOV. Ongoing painful synovitis was treated with an additional 80-mg intramuscular dose of methylprednisolone. On day 51, a midstream urine sample was EBOV PCR&#x2013;positive (C<sub>t</sub> value 35.7), and an underarm sweat swab sample was EBOV PCR&#x2013;negative. The patient was discharged; her family was advised to minimize contact with her body fluids.</p>
    <p>At follow-up on day 64, the patient&#x2019;s family reported she had impaired short-term memory and ongoing slowness. She had a score of 18/23 on the Mini&#x2013;Mental State Examination, but general neurologic exam results were normal. A midstream urine test was still EBOV PCR&#x2013;positive (C<sub>t</sub> value 39.6); PCR of her sweat swab sample was inhibited (<xref ref-type="local-data" rid="SD1">Technical Appendix</xref>). She was referred to the local survivors&#x2019; clinic; no contact cases were reported.</p>
    <p>The depressed mental status and presence of EBOV in this case-patient&#x2019;s CSF are consistent with encephalitis, a finding in autopsies of persons with Marburg virus infection (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>,<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>) and in EBOV nonhuman primate models (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>). The general atrophy seen in computer tomographic scan images is consistent with a rapidly developing complication of a diffuse inflammatory process. Given inadequate antimicrobial drug doses for meningitis and clinical improvement, we believe methicillin-resistant <italic>S. aureus</italic> and <italic>K. pneumoniae</italic> were CSF sample contaminants.</p>
    <p>This case shows the brain&#x2019;s immune privilege is incomplete for EBOV and prompts a broader discussion regarding neurovirulence in Ebola virus disease. Our finding that EBOV can be present in CSF, even after serum clearance, adds to the knowledge of neurologic symptoms in acute infection and of postinfectious sequelae in observational clinical studies (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>&#x2013;<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>). This finding raises the possibility that EBOV persistence elsewhere in the body, or in multiple organs, could be an indicator of or risk for central nervous system invasion. </p>
    <p>Our report has limitations. We could not perform many blood chemistry tests, in-country virus cultures, or deep sequencing on samples. Likewise, diagnosis of coma was challenging because of the lack of CSF cell counts, biochemistry values, and paired EBOV IgG and IgM titers in CSF and blood.</p>
    <p>This case raises the practical issue that Ebola treatment requires understanding of multiorgan virologic and inflammatory complications; survivor care and research programs should screen for neurocognitive impairment and consider appropriate imaging. The case confirms previously reported intermittent EBOV PCR positivity in urine (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>). The development of arthritis with synovitis, treated with corticosteroids, supports the diagnosis of reactive arthritis.</p>
    <supplementary-material content-type="local-data" id="SD1">
      <caption>
        <title>Technical Appendix</title>
        <p>Blood test and cycle threshold results for a 30-year-old woman with Ebola virus disease, Sierra Leone.</p>
      </caption>
      <media mimetype="application" mime-subtype="pdf" xlink:href="15-1212-Techapp-s1.pdf" xlink:type="simple" id="d36e257" position="anchor"/>
    </supplementary-material>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Howlett P, Brown C, Helderman T, Brooks T, Lisk D, Deen G, et al. Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone [letter]. Emerg Infect Dis. 2016 Jan [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid2201.151212">http://dx.doi.org/10.3201/eid2201.151212</ext-link></p>
      </fn>
    </fn-group>
    <bio id="d36e270">
      <p>Dr. Patrick Howlett works with the Kings Sierra Leone Partnership in Connaught Hospital. His areas of interest are respiratory medicine, tuberculosis, and strengthening health systems.</p>
    </bio>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="book"><string-name><surname>Logan</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Edward</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Saunders</surname>
<given-names>NA</given-names></string-name>. Real-time PCR: current technology and applications. Norfolk (UK): Caister Academic Press; <year>2009</year>. p. 421&#x2013;2.</mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Trombley</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Wachter</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Garrison</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Buckley-Beason</surname>
<given-names>VA</given-names></string-name>, <string-name><surname>Jahrling</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hensley</surname>
<given-names>LE</given-names></string-name>, <etal/>
<article-title>Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2010</year>;<volume>82</volume>:<fpage>954</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0636</pub-id><pub-id pub-id-type="pmid">20439981</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Bechtelsheimer</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Jacob</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Solcher</surname>
<given-names>H</given-names></string-name>. <article-title>The neuropathology of an infectious disease transmitted by African green monkeys (<italic>Cercopithecus aethiops</italic>).</article-title>
<source>Ger Med Mon</source>. <year>1969</year>;<volume>14</volume>:<fpage>10</fpage>&#x2013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">5389368</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="book"><string-name><surname>Jacob</surname>
<given-names>H</given-names></string-name>. The neuropathology of the Marburg disease in man. In: Martini GA, Siegert R, editors. Marburg virus disease. Berlin: Springer-Verlag; <year>1971.</year> p. 54&#x2013;61.</mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Larsen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Stevens</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Geibert</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Daddario-DiCaprio</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Jahrling</surname>
<given-names>PJ</given-names></string-name>, <etal/>
<article-title>Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus</article-title>. <source>J Infect Dis</source>. <year>2007</year>;<volume>196</volume>(<issue>Suppl 2</issue>):<fpage>S323</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1086/520589</pub-id><pub-id pub-id-type="pmid">17940967</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Bah</surname>
<given-names>EI</given-names></string-name>, <string-name><surname>Lamah</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Fletcher</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Jacob</surname>
<given-names>ST</given-names></string-name>, <string-name><surname>Brett-Major</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Sall</surname>
<given-names>AA, et al</given-names></string-name>. <article-title>Clinical presentation of patients with Ebola virus disease in Conakry, Guinea</article-title>. <source>N Engl J Med</source>. <year>2015</year>;<volume>372</volume>:<fpage>40</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1411249</pub-id><pub-id pub-id-type="pmid">25372658</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="other"><string-name><surname>Fitzpatrick</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Vogt</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Gbabai</surname>
<given-names>OM</given-names></string-name>, <string-name><surname>Decroo</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Keane</surname>
<given-names>M</given-names></string-name>, <string-name><surname>De Clerck</surname>
<given-names>H,</given-names></string-name>
<etal/> The contribution of Ebola viral load at admission and other patient characteristics to mortality in a M&#xE9;decins Sans Fronti&#xE8;res Ebola case management centre, Kailahun, Sierra Leone, June&#x2013;October, <year>2014</year> J Infect Dis. 2015 May 22 [Epub ahead of print]. <bold>PMID: 26002981</bold></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Bwaka</surname>
<given-names>MA</given-names></string-name>, Bonnet MJ, <string-name><surname>Calain</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Colebunders</surname>
<given-names>R</given-names></string-name>, De <string-name><surname>Roo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Guimard</surname>
<given-names>Y</given-names></string-name>, <etal/>
<article-title>Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.</article-title>
<source>J Infect Dis</source>. <year>1999</year>;<volume>179</volume>(<issue>Suppl 1</issue>):<fpage>S1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1086/514308</pub-id><pub-id pub-id-type="pmid">9988155</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Wolf</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kann</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Becker</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Stephan</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Brodt</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>de Leuw</surname>
<given-names>P</given-names></string-name>, <etal/>
<article-title>Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care.</article-title>
<source>Lancet</source>. <year>2015</year>;<volume>385</volume>:1428&#x2013;35. <pub-id pub-id-type="doi">10.1016/S0140-6736(14)62384-9</pub-id><pub-id pub-id-type="pmid">25534190</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
